A new blueprint for unlocking drug adoption in emerging markets Pharma companies or Sponsor Clients entering Emerging Asia Pacific face the same persistent challenge: patients want treatment, hospitals want to provide it, but affordability blocks the pathway . Yet despite the scale of the problem, market-access implementation has barely changed in decades. Programs remain: Slow to localize Fragmented across agencies Dependent on manual assessment High-risk in terms of complia

Our team at PSMO 39th Annual Convention Last week, Medscore had the honor of attending the Philippine Society of Medical Oncology (PSMO) Convention 2025 held in the Philippines. One of the region’s leading annual gatherings of oncologists, researchers and healthcare professionals across Southeast Asia to share ideas about the future of cancer care.  With the theme “𝑷𝑺𝑴𝑶 𝒂𝒕 𝒕𝒉𝒆 𝑯.𝑬.𝑨.𝑹.𝑻.” (Healthcare, Education, Access, Research & Transformation), this year’s c

[Jakarta, Indonesia] - [July 15, 2025] - Medscore, a leading provider of technology - driven patient access solutions, is proud to announce its official expansion into the Indonesian market, marking a strategic milestone in the company’s Asia-Pacific growth journey. Following extensive research, solution development and ongoing technological innovation, Medscore continues its mission to build a more efficient and inclusive healthcare ecosystem, where advanced technology serve

Medscore and MedAccess Broaden Asia Pacific Presence with Comprehensive Program Management Solutions [Jakarta, Indonesia] – [April 25, 2024] – MedScore, a leading tech provider of patient access solutions, is set to launch a nationwide patient access program in collaboration with a global sponsor company. The program will be rolled out in phases, ensuring a comprehensive digital transformation, encompassing enrollment, means testing, payment, and treatment onboarding.   This

[Singapore] – [August 1st, 2023] – Medscore , a pioneering healthcare technology company, is committed to transforming the landscape of cancer care in emerging markets. By leveraging advanced means testing software, Medscore empowers patients with cancer and rare diseases to access critical, life-saving treatments that were once out of reach due to affordability challenges ​ The Critical Role of Means Testing to revolutionize access to break-through treatment in emerging mark

Medscore Expands Global Reach, Bringing Hope to Filipino Cancer Patients with technology. [Manila, Philippines] – [November 25, 2024] –...

[Singapore] - [November, 2024] – Medscore, a pioneering healthcare technology company, is scheduled to intergrate its innovative means testing software with Singpass, Singapore’s national digital identity platform. ​ This integration empowers healthcare providers to instantly verify patient identity and conduct means testing, streamlining the process of accessing critical medications for underserved patients with cancer and rare diseases. Medscore’s mission is to accelerate d

​ [Hanoi, Vietnam] – [December 28, 2023] – MedScore, a leading software provider of patient access solutions, today received approval from the Vietnam Ministry of Health for its innovative cancer patient access programs offered by global pharmaceutical sponsor company.   The program leverages MedScore's innovative scoring solution (Means Testing) with geo-location intelligence and banking-level underwriting to digitally assess patients across emerging markets, ensuring they r